For doctors & nurse practitioners

Prescribers

How medicinal cannabis is lawfully prescribed in Australia, and how to obtain verified access to our formulary and clinical team.

Access pathways

SAS‑B and the Authorised Prescriber Scheme.

Both let you prescribe an unapproved medicinal cannabis product. They differ in who they cover, how long approval takes, and how much reporting you carry.

Comparison of the Special Access Scheme Category B and Authorised Prescriber Scheme
  Special Access Scheme — Category B Authorised Prescriber Scheme
Covers One named patient, one approval A class of patients with a specified condition, under one authority
Approval needed before prescribing Yes — TGA approval for that patient, plus any state or territory approval Yes — once, to become an Authorised Prescriber; then no per‑patient TGA application
Typical use Occasional prescribing, or a first patient Prescribing regularly to a defined patient group
Applied for by The prescribing practitioner, via the TGA SAS online system The practitioner, supported by an ethics committee approval or endorsement from a specialist college
State & territory approval Separately required in most jurisdictions for Schedule 8 products. The TGA SAS “single‑in” process notifies some states on your behalf — check the requirements where you practise.
Ongoing reporting Per approval, as conditioned Six‑monthly reporting of patient numbers to the TGA
Where to apply TGA — access pathways for medicinal cannabis
This is general information about a regulatory process, not clinical advice. Requirements change. Always confirm current requirements with the TGA and with the health department of your state or territory before prescribing.

Professional obligations

Professional obligations.

In July 2025 Ahpra published specific guidance on medicinal cannabis prescribing and has since taken action against practitioners. Worth reading in full before you start.

Ahpra guidance
  • Assess the patient properly Ahpra has criticised very short telehealth consultations and questionnaire‑driven prescribing that coaches patients toward a particular answer.
  • Consider conventional options first Medicinal cannabis is an unapproved medicine. The clinical reasoning for using one should be documented.
  • Manage conflicts of interest Single‑supplier arrangements and financial links between clinics and suppliers are explicitly flagged. Alma pays no prescriber inducements of any kind.
  • Advertising rules apply to you too A practitioner or clinic advertising these products to the public faces the same restrictions a sponsor does.

Access

What verified access includes.

Set out here rather than left behind the login.

01

Full formulary

Every product we supply, with composition, format, pack size, storage conditions, TGA category and current availability.

02

Batch certificates

Certificate of analysis for every released batch, searchable by batch number, downloadable as PDF.

03

Product information

Consumer medicine information and product documentation to support your consent conversation and your notes.

04

Clinical liaison

A direct line to our medical science liaison for product, formulation and pharmacology questions.

05

Application support

Practical help preparing SAS‑B submissions and Authorised Prescriber applications, including what the TGA typically asks for.

06

Education

Sessions on pharmacology, formulations, titration principles and monitoring, delivered by independent clinicians.

Verified access

How verification works.

Australian law permits product information about unapproved medicines to be given to health professionals, not to the public. Rather than a tick‑box declaration, we check your registration.

We verify the registration number you give us against the AHPRA public register before issuing credentials, and we keep a record of that check. It usually takes less than one business day.

Not a prescriber? Pharmacists should use the pharmacy application. Patients should speak with their own healthcare professional — we cannot give clinical or product advice to the public.

Prescriber access request

Fields marked * are required.

Three letters then ten digits, e.g. MED0001234567.
Current prescribing status

Alma Cannabis Pty Ltd (ABN 22 660 828 240) collects this information solely to verify your status as a health professional under section 42AA of the Therapeutic Goods Act 1989 (Cth) and to administer your access. We check your registration number against the AHPRA public register and retain a record of that check. We do not sell your data. Access, correction and complaints: privacy@cannabisalma.com. See our Privacy Policy.